Characteristic | N | % or IQR |
---|---|---|
Primary Sponsor | Â | Â |
  Non-industry | 298 | 62.5 |
  Industry | 179 | 37.5 |
Allocationa | Â | Â |
  Non-Randomized | 140 | 29.4 |
  Randomized | 329 | 69.0 |
Overall status | Â | Â |
  Not yet recruiting | 41 | 8.6 |
  Recruiting | 206 | 43.2 |
  Active not currently recruiting | 123 | 25.8 |
  Completed | 94 | 19.7 |
  Terminated | 13 | 2.7 |
Number of participantsa | Â | Â |
  Median (IQR) | 80 | 36, 179 |
  Less than or equal to 100 | 288 | 60.4 |
  101 to 1,000 | 173 | 36.3 |
  Greater than 1,000 | 14 | 2.9 |
Start yeara | Â | Â |
  Before 2007 | 63 | 13.2 |
  2007 | 42 | 8.8 |
  2008 | 130 | 27.3 |
  2009 | 137 | 28.7 |
  2010 | 98 | 20.6 |
Phase | Â | Â |
  2/3 | 284 | 59.5 |
  4 | 193 | 40.5 |
Study has DMCab | Â | Â |
  No | 207 | 43.4 |
  Yes | 189 | 39.6 |
Excludes > 65 years |  |  |
  No | 352 | 73.8 |
  Yes | 125 | 26.2 |
Number of study sitesa | Â | Â |
  Single facility | 205 | 43.0 |
  Multiple facilities | 225 | 47.2 |
Foreign sites | Â | Â |
  No | 126 | 26.4 |
  Yes | 351 | 73.6 |
Condition | Â | Â |
  Hepatitis C (HCV) | 156 | 32.7 |
  HIV/AIDS | 304 | 63.7 |
  HCV + HIV/AIDS | 17 | 3.6 |